365
Participants
Start Date
March 31, 2003
Primary Completion Date
April 30, 2004
Study Completion Date
April 30, 2004
Radafaxine
GSK Investigational Site, Washington D.C.
GSK Investigational Site, Rockville
GSK Investigational Site, Winston-Salem
GSK Investigational Site, Marietta
GSK Investigational Site, Jacksonville
GSK Investigational Site, Boynton Beach
GSK Investigational Site, Tampa
GSK Investigational Site, Nashville
GSK Investigational Site, Memphis
GSK Investigational Site, Toledo
GSK Investigational Site, Indianapolis
GSK Investigational Site, Lafayette
GSK Investigational Site, Libertyville
GSK Investigational Site, Oakbrook Terrace
GSK Investigational Site, Saint Charles
GSK Investigational Site, Shreveport
GSK Investigational Site, Albuquerque
GSK Investigational Site, Cerritos
GSK Investigational Site, San Diego
GSK Investigational Site, Bellevue
GSK Investigational Site, San Antonio
Lead Sponsor
GlaxoSmithKline
INDUSTRY